Lung cancer trials in Hong Kong

In Hong Kong 50 Also abroad 2746

50 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in Hong Kong
Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC
Where
Hong Kong
Age
18 years and over
People
100
Run by
Chinese University of Hong Kong
See details and how to joinNCT07722182
Phase 2Not yet taking people in Hong Kong
Study of Robotic Assisted/Image Guided Electromagnetic Navigation Bronchoscopic Therapies and Surgery in Stage IA NSCLC
Where
Hong Kong
Age
18 years and over
People
292
Run by
Chinese University of Hong Kong
See details and how to joinNCT07741344
Phase 1/2Taking people
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Where
Hong Kong, Shatin
Age
18 years and over
People
554 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00
Phase 3Taking people
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Where
Happy Valley, Hong Kong, Kowloon
Age
18 years and over
People
360 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07128199 · EU 2025-521775-31-00
Phase 2Taking people
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Where
Hong Kong
Age
18 years and over
People
40 worldwide
Run by
Pfizer
See details and how to joinNCT07476287 · EU 2025-524686-24-00
Phase 2Not yet taking people in Hong Kong
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Where
Hong Kong
Age
18 years and over
People
120 worldwide
Run by
Pfizer
See details and how to joinNCT07489066 · EU 2025-524825-42-00
Phase 2Taking people
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Where
Pok Fu Lam
Age
18 years and over
People
220 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT05967689
Phase 1Taking people
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Where
Hong Kong
Age
18 years and over
People
180 worldwide
Run by
Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193
Phase 1/2Taking people
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Where
Hong Kong, Jordan, Shatin
Age
18 years and over
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07286149 · EU 2024-512248-47-00
Phase 3Taking people
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Where
Hong Kong, Shatin
Age
18 years and over
People
450 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00
Phase 3Taking people
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Hong Kong, Jordan, Lai Chi Kok
Age
18 years and over
People
582 worldwide
Run by
AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00
No phaseTaking people
Acupressure for Cough in Lung Cancer Survivors
Where
Hong Kong
Age
18 years and over
People
80 worldwide
Run by
The University of Hong Kong
See details and how to joinNCT07315672
No phaseTaking people
Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong
Where
Hong Kong
Age
25 years to 65 years
People
574
Run by
The University of Hong Kong
See details and how to joinNCT07720245
Phase 1/2Taking people
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Where
Hong Kong
Age
18 years and over
People
180 worldwide
Run by
Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00
No phaseTaking people
Screening for Lung Cancer in Subjects With Family History of Lung Cancer
Where
Hong Kong
Age
50 years to 75 years
People
1,520
Run by
The University of Hong Kong
See details and how to joinNCT05762731
No phaseNot yet taking people in Hong Kong
ctDNA Mutations and Methylation Status for Early Detection of Lung Cancer in Patients With Suspicious Lung Nodules
Where
Hong Kong
Age
45 years to 80 years
People
200
Run by
The University of Hong Kong
See details and how to joinNCT07615556
No phaseTaking people
Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations
Where
Hong Kong
Age
65 years and over
People
150 worldwide
Run by
University of Malaya
See details and how to joinNCT07369596
Phase 1/2Active, not recruiting
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Hong Kong
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study
Where
Shatin
Age
18 years and over
People
25
Run by
Galvanize Therapeutics, Inc.
See details and how to joinNCT07487064
No phaseTaking people
Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device
Where
Hong Kong
Age
50 years to 75 years
People
3,000
Run by
Chinese University of Hong Kong
See details and how to joinNCT06295497
No phaseNot yet taking people in Hong Kong
Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong
Where
Hong Kong
Age
50 years to 79 years
People
15,000
Run by
The University of Hong Kong
See details and how to joinNCT07478757
Phase 2Taking people
Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer
Where
Hong Kong
Age
18 years and over
People
64
Run by
Chinese University of Hong Kong
See details and how to joinNCT07379476
Phase 1Taking people
A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
Where
Hong Kong
Age
18 years and over
People
122 worldwide
Run by
Chugai Pharmaceutical
See details and how to joinNCT07107490
No phaseNot yet taking people in Hong Kong
Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment
Where
Shatin
Age
18 years to 80 years
People
40 worldwide
Run by
Tianjin Puli Ark Medical Technology Co., Ltd.
See details and how to joinNCT07301411
No phaseTaking people
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
Where
Hong Kong
Age
18 years to 100 years
People
320
Run by
The University of Hong Kong
See details and how to joinNCT06377124